The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration
- PMID: 10562649
The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration
Abstract
Geographic atrophy is the advanced form of atrophic age-related macular degeneration. It is present in 3.5% of people age 75 and over in the United States. It progresses gradually over time, often sparing the fovea until late in the course of the disease. Forty to fifty percent of eyes with geographic atrophy and good visual acuity at baseline lose three or more lines of acuity by two years and 27% become worse than 20/200 by four years. This article discusses the information known about age-related geographic atrophy at the present time.
Similar articles
-
Subfoveal exudative age-related macular degeneration: evidence for preoccult disease.Curr Opin Ophthalmol. 2009 May;20(3):182-7. doi: 10.1097/ICU.0b013e328329b669. Curr Opin Ophthalmol. 2009. PMID: 19367162 Review.
-
Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial.Ophthalmology. 2008 Sep;115(9):1474-9, 1479.e1-6. doi: 10.1016/j.ophtha.2008.03.008. Epub 2008 May 27. Ophthalmology. 2008. PMID: 18502512 Clinical Trial.
-
Laser treatment in patients with bilateral large drusen: the complications of age-related macular degeneration prevention trial.Ophthalmology. 2006 Nov;113(11):1974-86. doi: 10.1016/j.ophtha.2006.08.015. Ophthalmology. 2006. PMID: 17074563 Clinical Trial.
-
[Natural course and prognosis of visual acuity in patients of age-related macular degeneration with occult choroidal neovascularization].Zhonghua Yan Ke Za Zhi. 2003 Jul;39(7):415-8. Zhonghua Yan Ke Za Zhi. 2003. PMID: 12921672 Chinese.
-
New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.Indian J Ophthalmol. 2000 Dec;48(4):263-78. Indian J Ophthalmol. 2000. PMID: 11340884 Review.
Cited by
-
Evaluation of a Digital Amsler Grid (PocDoc) for Macular Disease Screening: A Comparative Analysis with the Conventional Method.Ophthalmol Ther. 2024 May;13(5):1289-1301. doi: 10.1007/s40123-024-00910-5. Epub 2024 Mar 20. Ophthalmol Ther. 2024. PMID: 38507191 Free PMC article.
-
Considerations for the Identification and Management of Geographic Atrophy: Recommendations from an Expert Panel.Clin Ophthalmol. 2024 Feb 2;18:325-335. doi: 10.2147/OPTH.S445755. eCollection 2024. Clin Ophthalmol. 2024. PMID: 38332904 Free PMC article.
-
Patient acceptability of intravitreal complement inhibitors in geographic atrophy (GA): protocol for a UK-based cross-sectional study.BMJ Open. 2024 Jan 18;14(1):e075713. doi: 10.1136/bmjopen-2023-075713. BMJ Open. 2024. PMID: 38238063 Free PMC article.
-
Treating patients with geographic atrophy: are we there yet?Int J Retina Vitreous. 2023 Nov 20;9(1):72. doi: 10.1186/s40942-023-00493-6. Int J Retina Vitreous. 2023. PMID: 37986170 Free PMC article. Review.
-
Geographic Atrophy Management Consensus (GA-MAC): a Delphi panel study on identification, diagnosis and treatment.BMJ Open Ophthalmol. 2023 Oct;8(1):e001395. doi: 10.1136/bmjophth-2023-001395. BMJ Open Ophthalmol. 2023. PMID: 37857560 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical